Elevation of arginine vasopressin levels following loop diuretic therapy as a prognostic indicator in heart failure
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevation of arginine vasopressin levels following loop diuretic therapy as a prognostic indicator in heart failure
Authors
Keywords
-
Journal
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Volume 44, Issue 6, Pages 1430-1442
Publisher
SAGE Publications
Online
2016-10-28
DOI
10.1177/0300060516663779
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low Cardiac Output Stimulates Vasopressin Release in Patients With Stage D Heart Failure
- (2014) Teruhiko Imamura et al. CIRCULATION JOURNAL
- Efficacy and Safety of Tolvaptan in Heart Failure Patients With Volume Overload
- (2014) Koichiro Kinugawa et al. CIRCULATION JOURNAL
- Decongestive Therapy and Renal Function in Acute Heart Failure
- (2014) Steven R. Goldsmith et al. Circulation-Heart Failure
- 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
- (2013) Clyde W. Yancy et al. CIRCULATION
- Loop Diuretic Efficiency
- (2013) Jeffrey M. Testani et al. Circulation-Heart Failure
- Association of Arginine Vasopressin Levels With Outcomes and the Effect of V2 Blockade in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
- (2012) David E. Lanfear et al. Circulation-Heart Failure
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
- (2012) et al. EUROPEAN HEART JOURNAL
- Plasma Copeptin Levels and Prediction of Outcome in Heart Failure Outpatients: Relation to Hyponatremia and Loop Diuretic Doses
- (2012) Louise Balling et al. JOURNAL OF CARDIAC FAILURE
- Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
- (2012) Taka-aki Koshimizu et al. PHYSIOLOGICAL REVIEWS
- Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?
- (2011) Marco Metra et al. Circulation-Heart Failure
- Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH)
- (2011) Natig Gassanov et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Tolvaptan for the treatment of heart failure: a review of the literature
- (2011) Andrew Ambrosy et al. EXPERT OPINION ON PHARMACOTHERAPY
- Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart Failure
- (2010) Jacob C. Jentzer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Use of Diuretics in Patients with Hypertension
- (2009) Michael E. Ernst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Intravenous Loop Diuretics on Outcomes of Patients Hospitalized with Acute Decompensated Heart Failure: Insights from the ADHERE Registry
- (2008) W. Franklin Peacock et al. CARDIOLOGY
- Arginine Vasopressin Antagonists for the Treatment of Heart Failure and Hyponatremia
- (2008) John J. Finley et al. CIRCULATION
- Non-peptide arginine-vasopressin antagonists: the vaptans
- (2008) Guy Decaux et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation